Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Sitagliptin
is a highly potent and orally bioavailable PI3K/mTOR dual inhibitor developed through structure-based drug design
is a novel plasminogen activator inhibitor-1 (PAI-1) inhibitor
Formula: C21H21Cl2NO5
Rifaximin Size:Solid 10 mg SitagliptinRifaximin is a semisynthetic antibiotic based on rifamycin. It has poor oral bioavailability, meaning that very little of the drug will be absorbed into the blood stream when it is taken orally. Rifaximin is used in the treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy, for which it received orphan drug status from the U. S. Food and Drug Administration in 1998. Rifaximin interferes with transcription by binding to
US$ 109021.50
US$ 1319.50
US$ 1257.00
US$ 3011.50
US$ 2242.00
US$ 1099.50
US$ 1499.00
US$ 1632.00
US$ 3021.00
US$ 1931.50
US$ 296092.50